EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Next-Generation Sequencing in Colorectal Cancer: Real-World Molecular Profiling and Clinical Correlations

Afonso Cunha iD, Carolina Robalo iD, Carolina Lemos, Nuno Jorge Lamas, Marisa Domingues Dos Santos iD

International Journal of Molecular Sciences · 01.08.2026 · 27 (15) · 6930

DOI: 10.3390/ijms27156930 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 01.08.2026. Verfasst von Afonso Cunha und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine and Biomedical Sciences, University of Porto, Rua Jorge de Viterbo Ferreira, 228, 4050-313 Porto, Portugal. Hauptthemen laut MEDLINE: Colorectal Neoplasms, High-Throughput Nucleotide Sequencing. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidade do Porto, Unidade Multidisciplinar de Investigação Biomédica, Fundação para a Ciência e a Tecnologia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Next-generation sequencing (NGS) has become a cornerstone of precision oncology in colorectal cancer (CRC), although its role in routine patient stratification remains incompletely defined. This retrospective single-centre study characterised the molecular landscape of clinically selected CRC patients undergoing routine NGS and explored associations between genomic alterations and clinicopathological features. 97 eligible patients who underwent targeted NGS using two validated sequencing platforms were selected. Demographic, clinicopathological, and molecular data were integrated, and associations were evaluated using descriptive statistics, exploratory association testing, principal component analysis, and multiple correspondence analysis. At least one reportable genetic alteration was identified in 91 patients (93.8%), comprising 198 alteration events across multiple cancer-related genes. The most frequently altered genes with pathogenic or likely pathogenic variants were TP53 (55.7%), KRAS (40.2%), PIK3CA (18.6%), and BRAF (11.5%), while microsatellite instability was detected in 19.1% of evaluable tumours. Exploratory analyses identified associations between selected molecular alterations and clinicopathological characteristics. However, these were generally modest, frequently limited by small subgroup sizes, and none survived Benjamini–Hochberg correction. Principal component analysis demonstrated substantial molecular heterogeneity without defining distinct clinicopathological subgroups. Routine targeted NGS provides detailed molecular characterisation of CRC and generates information relevant to biomarker-informed clinical decision-making in real-world practice. However, targeted panels alone were insufficient to establish robust molecular subgroups in this retrospective cohort. These findings highlight the biological complexity of CRC and support larger prospective studies incorporating broader molecular profiling to improve precision patient stratification and optimise personalised therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsHigh-Throughput Nucleotide SequencingHumansFemaleMaleAgedMiddle AgedMutationMicrosatellite InstabilityRetrospective StudiesBiomarkers, TumorProto-Oncogene Proteins B-rafAdultAged, 80 and overClass I Phosphatidylinositol 3-Kinases

Stichwörter der Autor:innen

clinical phenotypescolorectal cancermolecular profilingnext-generation sequencingsomatic alterations

Substanzen

Biomarkers, TumorProto-Oncogene Proteins B-rafClass I Phosphatidylinositol 3-KinasesBRAF protein, human

Autor:innen und Institutionen

  • School of Medicine and Biomedical Sciences, University of Porto, Rua Jorge de Viterbo Ferreira, 228, 4050-313 Porto, Portugal.
  • Unidade de Cirurgia Colorretal, Serviço de Cirurgia Digestiva e Extradigestiva, Unidade Local de Saúde de Santo António, 4050-313 Porto, Portugal.
  • Unit for Multidisciplinary Research in Biomedicine, School of Medicine and Biomedical Sciences, University of Porto, Rua Jorge de Viterbo Ferreira, 228, 4050-313 Porto, Portugal.
  • ITR-Laboratory for Integrative and Translational Research in Population Health, 4050-313 Porto, Portugal.
  • Serviço de Anatomia Patológica, Clínica de Patologia e Genética Unidade Local de Saúde de Santo António, 4050-313 Porto, Portugal.
  • Escola de Medicina, Universidade do Minho, Campus de Gualtar, Edifício 19, 4710-057 Braga, Portugal.

ORCID-Profile: Afonso Cunha, Carolina Robalo, Marisa Domingues Dos Santos

Förderung

  • Universidade do Porto
  • Unidade Multidisciplinar de Investigação Biomédica
  • Fundação para a Ciência e a Tecnologia

Zitieren

APA

Cunha, A., Robalo, C., Lemos, C., Lamas, N. J., & Dos Santos, M. D. (2026). Next-Generation Sequencing in Colorectal Cancer: Real-World Molecular Profiling and Clinical Correlations. International Journal of Molecular Sciences, 27(15), 6930. https://doi.org/10.3390/ijms27156930

Vancouver

Cunha A, Robalo C, Lemos C, Lamas NJ, Dos Santos MD. Next-Generation Sequencing in Colorectal Cancer: Real-World Molecular Profiling and Clinical Correlations. International Journal of Molecular Sciences. 2026;27(15):6930. doi:10.3390/ijms27156930

BibTeX
@article{Cunha2026,
  author = {Cunha, Afonso and Robalo, Carolina and Lemos, Carolina and Lamas, Nuno Jorge and Dos Santos, Marisa Domingues},
  title = {Next-Generation Sequencing in Colorectal Cancer: Real-World Molecular Profiling and Clinical Correlations},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {15},
  pages = {6930},
  doi = {10.3390/ijms27156930}
}
Kostenlos starten →